235 related articles for article (PubMed ID: 15378234)
21. The comparison of artificial urinary sphincter implantation and endourethral macroplastique injection for the treatment of postprostatectomy incontinence.
Imamoglu MA; Tuygun C; Bakirtas H; Yiğitbasi O; Kiper A
Eur Urol; 2005 Feb; 47(2):209-13. PubMed ID: 15661416
[TBL] [Abstract][Full Text] [Related]
22. Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial.
Maher CF; O'Reilly BA; Dwyer PL; Carey MP; Cornish A; Schluter P
BJOG; 2005 Jun; 112(6):797-801. PubMed ID: 15924540
[TBL] [Abstract][Full Text] [Related]
23. Clinical presentation and treatment of Macroplastique® urethral exposures: a retrospective case series.
Ramirez-Caban L; Malekzadeh M; Ossin DA; Hurtado EA
Int Urogynecol J; 2022 Mar; 33(3):681-687. PubMed ID: 34213601
[TBL] [Abstract][Full Text] [Related]
24. Long-term subjective continence status and use of alternative treatments by women with stress urinary incontinence after collagen injection therapy.
Sakamoto K; Sharma S; Wheeler JS
World J Urol; 2007 Aug; 25(4):431-3. PubMed ID: 17593370
[TBL] [Abstract][Full Text] [Related]
25. Effects of laser procedure for female urodynamic stress incontinence on pad weight, urodynamics, and sexual function.
Tien YW; Hsiao SM; Lee CN; Lin HH
Int Urogynecol J; 2017 Mar; 28(3):469-476. PubMed ID: 27631824
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of polydimethylsiloxane (Macroplastique®) in women with stress urinary incontinence: analysis of data from patients who completed three years follow-up.
Ghoniem G; Farhan B; Chowdhury ML; Chen Y
Int Urogynecol J; 2021 Oct; 32(10):2835-2840. PubMed ID: 34100973
[TBL] [Abstract][Full Text] [Related]
27. Macroplastique for women with stress urinary incontinence secondary to intrinsic sphincter deficiency.
Carroll TF; Christie A; Foreman M; Khatri G; Zimmern PE
Int Braz J Urol; 2019; 45(5):989-998. PubMed ID: 31626522
[TBL] [Abstract][Full Text] [Related]
28. Nonabsorbable urethral bulking agent - clinical effectiveness and late complications rates in the treatment of recurrent stress urinary incontinence after 2 years of follow-up.
Futyma K; Nowakowski Ł; Gałczyński K; Miotła P; Rechberger T
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():68-72. PubMed ID: 27825030
[TBL] [Abstract][Full Text] [Related]
29. Three-dimensional endovaginal ultrasound examination following injection of Macroplastique for stress urinary incontinence: outcomes based on location and periurethral distribution of the bulking agent.
Hegde A; Smith AL; Aguilar VC; Davila GW
Int Urogynecol J; 2013 Jul; 24(7):1151-9. PubMed ID: 23229417
[TBL] [Abstract][Full Text] [Related]
30. Collagen for female genuine stress incontinence after a minimum 2-year follow-up.
Swami S; Batista JE; Abrams P
Br J Urol; 1997 Nov; 80(5):757-61. PubMed ID: 9393298
[TBL] [Abstract][Full Text] [Related]
31. Urodynamic evaluation: can it prevent the need for surgical intervention in women with apparent pure stress urinary incontinence?
Serati M; Cattoni E; Siesto G; Braga A; Sorice P; Cantaluppi S; Cromi A; Ghezzi F; Vitobello D; Bolis P; Salvatore S
BJU Int; 2013 Aug; 112(4):E344-50. PubMed ID: 23421421
[TBL] [Abstract][Full Text] [Related]
32. Mersilene mesh sling: short- and long-term clinical and urodynamic outcomes.
Young SB; Howard AE; Baker SP
Am J Obstet Gynecol; 2001 Jul; 185(1):32-40. PubMed ID: 11483900
[TBL] [Abstract][Full Text] [Related]
33. Endoscopic correction of intractable stress incontinence with silicone micro-implants.
Sheriff MK; Foley S; Mcfarlane J; Nauth-Misir R; Shah PJ
Eur Urol; 1997; 32(3):284-8. PubMed ID: 9358214
[TBL] [Abstract][Full Text] [Related]
34. Is there a role for periurethral collagen injection in the management of urodynamically proven mixed urinary incontinence?
Poon CI; Zimmern PE
Urology; 2006 Apr; 67(4):725-9; discussion 729-30. PubMed ID: 16618559
[TBL] [Abstract][Full Text] [Related]
35. A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence.
Ghoniem GM; Miller CJ
Int Urogynecol J; 2013 Jan; 24(1):27-36. PubMed ID: 22699885
[TBL] [Abstract][Full Text] [Related]
36. The "1-3-5 cough test": comparing the severity of urodynamic stress incontinence with severity measures of subjective perception of stress urinary incontinence.
Grigoriadis T; Giannoulis G; Zacharakis D; Protopapas A; Cardozo L; Athanasiou S
Int Urogynecol J; 2016 Mar; 27(3):419-25. PubMed ID: 26239956
[TBL] [Abstract][Full Text] [Related]
37. One year follow-up on the SPARC sling system for the treatment of female urodynamic stress incontinence.
Primus G
Int J Urol; 2006 Nov; 13(11):1410-4. PubMed ID: 17083393
[TBL] [Abstract][Full Text] [Related]
38. Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy.
Chapple CR; Brubaker L; Haab F; van Kerrebroeck P; Robinson D
Int Urogynecol J Pelvic Floor Dysfunct; 2007 Feb; 18(2):199-205. PubMed ID: 16847584
[TBL] [Abstract][Full Text] [Related]
39. Long-term efficacy of polydimethylsiloxane (Macroplastique) injection for Mitrofanoff leakage after continent urinary diversion surgery.
Kass-iliyya A; Rashid TG; Citron I; Foley C; Hamid R; Greenwell TJ; Shah PJ; Ockrim JL
BJU Int; 2015 Mar; 115(3):461-5. PubMed ID: 24862487
[TBL] [Abstract][Full Text] [Related]
40. Periurethral collagen injection: a long-term follow-up study.
Gorton E; Stanton S; Monga A; Wiskind AK; Lentz GM; Bland DR
BJU Int; 1999 Dec; 84(9):966-71. PubMed ID: 10571621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
